Emanuel Schenck is currently the Principal Clinical Biomarker Lead Pathology at Boehringer Ingelheim and has been serving as Head Pathologist in Oncology Safety at AstraZeneca since 2019. Previously, Emanuel held significant roles such as Head Pathologist at MedImmune from 2011 to 2019 and Senior Director at Pfizer from 2002 to 2011. Emanuel earned a Dr. med. vet. in Veterinary Pathology from Ludwig-Maximilians-Universität München and a PhD in Veterinary Pathology from The Ohio State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices